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Summary
The expression of bacterial polyketide synthase gene clusters is often controlled by a
number of different families of regulatory proteins that can have either a pathway-specific
or a pleiotropic mode of action, e.g. the SARP family (Streptomyces antibiotic regulatory
proteins), ribosome-associated ppGpp synthetase, g-butyrolactone-binding regulatory pro-
teins, and two-component regulatory proteins. The molecular genetics of such regulatory
mechanisms that govern the biosynthesis of tetracyclines is poorly understood. In this work,
a comparative bioinformatic analysis of regulatory genes present in three tetracycline anti-
biotic gene clusters, namely oxytetracycline (OTC), chlortetracycline and recently cloned
chelocardin gene clusters of S. rimosus, S. aureofaciens and Amycolatopsis sulphurea has been
performed. A SARP family regulatory protein is located in the chlortetracycline gene clu-
ster, but is not detected in the gene cluster encoding OTC biosynthesis. Interestingly, the
only regulatory element identified in chelocardin gene cluster was chdA, an otrR and ctcR
homologue from the TetR family of regulators that regulates the expression of the otrB and
ctc05 exporter genes in the oxytetracycline and chlortetracycline gene clusters. In the oxy-
tetracycline gene cluster, a new LAL (LuxR) family regulatory gene homologue, otcG, was
identified. This homologue is also present in the ctc gene cluster. By gene disruption and
overexpression experiments, a 'conditionally positive' role of otcG in OTC biosynthesis has
been demonstrated. The observation, the bioinformatics data and the previous work on
phosphate regulation suggest the presence of a more complex, fine tuning role of the otcG
gene product in overall expression of genes for OTC biosynthesis.
Key words: type II polyketide synthase, oxytetracycline biosynthesis, Streptomyces rimosus,
regulatory gene, LAL (LuxR) family regulator, gene cluster, chelocardin, Amycolatopsis sul-
phurea
Introduction
Chlortetracycline (CTC) and oxytetracycline (OTC)
produced by Streptomyces aureofaciens and S. rimosus, re-
spectively, were the first members of the tetracycline
antibiotic family to reach the clinic. Historically, several
research groups have focused on different aspects of the
biosynthesis of tetracyclines (1–5). For the extensive ref-
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erence list see the recent review of Petkovi} et al. (6).
Chelocardin (CHD) on the other hand, produced by
Amycolatopsis sulphurea, is also a powerful tetracycline
antibiotic with an unknown mode of action, but it did
not reach the clinic (7,8). We have recently cloned the
entire gene cluster encoding CHD biosynthesis from A.
sulphurea (unpublished results).
The expression of polyketide synthase (PKS) gene
cluster elements is often controlled by a number of dif-
ferent families of regulatory proteins that can have ei-
ther a pathway-specific or a pleiotropic mode of action
(9). The SARP family (Streptomyces antibiotic regulatory
proteins) of positive regulatory proteins encoding genes
for pathway-specific transcriptional regulation are the
most common positive regulators of type II PKS gene
cluster (10). These proteins tend to interact with promot-
ers of genes (gene clusters) involved in antibiotic bio-
synthesis and are generally found in a number of PKS
clusters including the type II PKS gene clusters of acti-
norhodin and daunorubicin (11,12). Some examples of the
more general pleiotropic signals affecting biosynthesis of
type II PKSs include the ribosome-associated ppGpp
synthetase (RelA) (9), g-butyrolactone-binding regulatory
proteins (13), and two-component regulators (14). Ex-
cluding the publication on phosphate regulation by Mc-
Dowall et al. (15), any other information on the molecu-
lar genetics of the regulatory mechanisms governing the
biosynthesis of OTC in S. rimosus has not been found.
Based on a comparative bioinformatics study of the
gene clusters encoding OTC and CTC biosynthesis, we
have identified a new LAL (LuxR) family regulatory
gene in the otc gene cluster. Interestingly, numerous
gene clusters encoding type I PKSs contain the so-called
LAL (LuxR) family of transcriptional regulators, such as
positive regulators RapG from the rapamycin gene clus-
ter, PimM from the pimaricin gene cluster, and PikD
from the pikromycin gene cluster (16–18), which are
usually not found in type II PKS gene clusters.
In this work a detailed analysis of the regulatory el-
ements potentially regulating OTC biosynthesis in S.
rimosus has been carried out. Putative regulatory ele-
ments present in the chd gene cluster from A. sulphurea
have also been analysed. Apart from SARP and tetR-like
regulatory protein, a new LAL (LuxR) gene homologue,
otcG, has been identified in the otc gene cluster. Its 'con-
ditionally positive' role in the biosynthesis of OTC has
been demonstrated.
Materials and Methods
Bacterial strains and culture conditions
S. rimosus M4018 (19) was used as the donor of DNA
and as the host for gene disruption and overexpression
experiments. Electroporation of S. rimosus was performed
as described previously (20). For sporulation and selec-
tion of morphological variants and resistance pheno-
types, S. rimosus was grown on soya mannitol medium
(21). The S. rimosus ATCC10970 wild type strain (4), and
the industrial high-producing strain S. rimosus AB04
(Acies Bio Ltd., Ljubljana, Slovenia) were used for DNA
isolation and otcG sequencing. S. rimosus strains were
maintained and grown in fermentation medium as de-
scribed previously (22). Thiostrepton (30 μg/mL in solid
medium and 5 μg/mL in liquid medium) and erythro-
mycin (50 μg/mL) were added to the media as required.
A. sulphurea NRRL 2822 strain (8) was used as a source
of genomic DNA for cloning the chd gene cluster. Esche-
richia coli DH10b (23) was used for cloning and E. coli
ET12567 (24) for obtaining unmethylated DNA for trans-
formation into S. rimosus. E. coli cultures were grown on
2TY medium at 37 °C, supplemented with ampicillin
(100 μg/mL) and apramycin (50 μg/mL), as required.
Plasmids and Streptomyces rimosus strains used in this
study are described in Table 1.
DNA manipulations
Standard methods for isolation and manipulation of
DNA were performed as described by Sambrook and
Russel (25) and Kieser et al. (21). Southern hybridization
was undertaken using the non-radioactive DIG DNA La-
belling and Detection Kit from Roche (Mannheim, Ger-
many), according to the manufacturer’s instructions. For
PCR amplification of the complete otcG gene (714 bp)
the primers otcGF: 5’-GGCATATGGATAACAAAGTC-
ATC-3’ and otcGR: 5’-TCAGGTGCCGGCCTGTAC-3’
were used. An NdeI restriction site was included in one
primer to facilitate subcloning and is indicated by un-
derscoring. For the truncated sequence of the otcG gene,
the primers partF: 5’-AAGTCATCACCGTCCTCGTC-3’
and partR: 5’-CGCCACGTTCTCCATTATCT-3’ were used,
amplifying nucleotides 11 to 480.
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Cloning of the chd gene cluster
A SuperCos1-based genomic library of A. sulphurea
NRRL 2822 genomic DNA was constructed by using the
Gigapack® III Gold Packaging Kit (Stratagene). The li-
brary was screened by colony hybridization for the pres-
ence of a type II PKS gene cluster using a ketosynthase
(KSa) gene from the OTC gene cluster as a probe. The
selected clone was sequenced (Macrogen, Korea) and
putative open reading frames (ORFs) were determined
using the FramePlot beta 4.0. software (26). The putative
gene functions were determined using the BLASTx algo-
rithm at the NCBI (27).
Plasmids
The PCR products of the complete (714 bp) and
truncated (470 bp) otcG putative regulator gene were
cloned into pGEM-T easy plasmid (Promega, Germany)
and confirmed by sequencing. The complete otcG gene
was excised with NdeI and cloned into the NdeI site of
pSGset2 (21) downstream of the ermE promoter. The
HindIII fragment carrying the ermE-otcG construct was
cloned into the HindIII site of the pTS55 integrative vec-
tor (28), resulting in the pTS55ermE-otcG plasmid. For
the disruption of otcG gene, a suicide vector pDotcG was
constructed by cloning the EcoRI fragment with the trun-
cated otcG sequence from the pGEM-T easy plasmid into
the EcoRI site of the pIJ4026 suicide plasmid (21).
Gene inactivation and overexpression
For the inactivation of the otcG gene, a suicide pDotcG
vector was used. The pDotcG vector contained a 470-bp
internal fragment of otcG. Single-crossover recombinants
were selected by their resistance to erythromycin. For
the overexpression of otcG, the pTS55ermE-otcG plasmid,
a pTS55-based integrative vector with an intact otcG
gene downstream of the ermE promoter, was used. The
transformants were selected using thiostrepton. Since
the OTC-producing strains of S. rimosus often display a
very high degree of morphological instability which also
causes a significant variability in the final OTC yield,
only transformants with the correct 'wild-type' colony
phenotype were selected. Fermentations using the se-
lected colonies (transformants) of all mutants were un-
dertaken in parallel to ensure reproducibility. Genetic in-
stability, often accompanied with gene deletion and/or
DNA amplification (29,30) of the otc gene cluster did not
occur, as confirmed by DNA restriction analysis and gel
electrophoresis, and finally by Southern hybridization.
The OTC production of 18 S. rimosus M4018 colonies
with a disrupted copy of otcG (pDotcG) and 42 colonies
with an additional copy under the ermE promoter (pTS55-
ermE-otcG) were compared to 12 colonies of S. rimosus
M4018 with pTS55 as a control. The yields were ana-
lyzed using the SAS/STAT program and expressed as
the least square means with standard errors of the means.
OTC analytical method
Accumulation of oxytetracycline during fermenta-
tion was measured by reversed-phase HPLC according
to European Pharmacopoeia 5.5 (31). The 714-bp se-
quence for the oxytetracycline regulatory gene, otcG, re-
ported here has been deposited in GenBank under ac-
cession number FJ503048.
Results
Regulatory elements present in the ctc, otc and chd
gene clusters
The gene cluster encoding OTC biosynthesis from
the S. rimosus strain M4018 was defined as a 34-kb EcoRI-
-fragment that conferred OTC production on the naïve
host, S. lividans (32). Parts of that otc gene cluster and
the entire gene cluster derived from low-producing strain
ATCC 10970 have been sequenced (4). Gene organiza-
tion of both otc gene clusters derived from M15883 and
ATCC10970 S. rimosus strains is identical. On the other
hand, comparative analysis of the gene organization be-
tween otc and ctc gene clusters revealed significant dif-
ferences, including the regulatory genes (Fig. 1).
When analysing the ORFs of the ctc gene cluster
(33), regulatory elements can be identified at both ex-
tremities of the gene cluster. On the right extremity of
the ctc gene cluster (Fig. 1a), a tetR-family homologue of
the repressor regulatory element ctcR can be identified,
adjacent to the exporter gene ctc05. Analogously to the
ctc gene cluster, the counterparts of the ctc05/ctcR, the
otrB/otrR homologues from the otc (2), are located at the
right extremity of the otc gene cluster (Fig. 1b), albeit in
the opposite orientation with respect to the biosynthetic
genes.
The tetR-like repressor from the otc gene cluster en-
codes the MarR (multiple antibiotic resistance regulator)
protein, which was originally characterized as the repres-
sor of the multiple antibiotic resistance operon marRAB
in Escherichia (34). The TetA system of the transposon
Tn10, which is a paradigm of this class of resistance, has
been studied extensively (35). The TetR homologue in
OTC biosynthesis regulates the expression of the export-
er (36). However, it is not clear whether the otrR gene
product is solely involved in the regulation of otrB or
also in the regulation of other genes in the cluster. Two
ORFs encoding transcriptional regulators can be identi-
fied on the left extremity of the ctc gene cluster in S.
aureofaciens, just adjacent to the ribosomal tetracycline
resistance gene ctc14, as reported earlier (Fig. 1a; 33).
Both gene homologues belong to the putative positive
regulatory genes according to BLAST homology searches.
The ctc11 gene homologue is a typical SARP family, pos-
itive pathway specific transcriptional regulator, such as
the actII-ORF4 in the actinorhodin gene cluster in S. co-
elicolor (37). The ORF ctc13, which is located at the ex-
treme left fringe of the ctc cluster, adjacent to the SARP
family homologue and transcribed in the opposite direc-
tion of the ctc11 gene, is a homologue of two component
transcriptional regulators of the LAL (LuxR) family (Fig.
1a). We have identified a new ORF designated as otcG in
the otc cluster, with a high homology to the ctc13 gene
in the ctc gene cluster, designated according to Hunter
and Hill (2). The otcG gene lies adjacent to the otrA gene
(encoding ribosomal resistance) and it is expressed in the
opposite orientation. Surprisingly, no ctc11 gene homo-
logue encoding a SARP pathway specific regulator could
be identified in the OTC gene cluster (Fig. 1b). Interest-
ingly, only chdA and chdR, the otrR and otrB homologues
from oxytetracycline gene cluster, can be identified in the
chelocardin gene cluster (Fig. 1c).
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Database comparisons revealed that the otcG gene
product (237 aa) has amino acid sequence homology with
the LAL (LuxR) family of bacterial regulatory proteins, a
putative two-component system response transcriptional
regulatory protein. The characteristic architecture of the
LAL (LuxR) family of DNA binding proteins, containing
a nucleotide triphosphate (NTP) binding motif at the N-
-terminus and a C-terminally-located helix-turn-helix
(HTH) motif, can be clearly assigned to the otcG gene
product (Fig. 2).
Interestingly, there is a rare TTA codon within the
coding region of the otcG gene (Fig. 2), which is charac-
teristic of many SARP genes and can have a profound
influence on secondary metabolism and morphological
differentiation, as demonstrated in S. coelicolor (9) where
the appearance of the tRNA associated with the TTA
codon is developmentally-regulated. Considering the in-
teresting features of the otcG gene and its putative role
in the regulation of OTC biosynthesis in S. rimosus, we
have also sequenced this gene homologue in the two in-
dependent strains, namely S. rimosus ATCC10970 wild
type strain (4), and the industrial high-producing strain
S. rimosus AB04 (DNA provided by Acies Bio Ltd., Slo-
venia). Sequencing of the otcG gene from all three strains
revealed 100 % identity at the DNA level (data not
shown); therefore, no mutation was introduced in the
otcG gene during the intensive strain improvement pro-
cesses carried out over the years.
When a putative gene cluster encoding CHD was
compared to the ctc and otc gene clusters (Fig. 1), no
SARP or LAL (LuxR) family of bacterial regulatory pro-
teins were detected in the chd gene cluster. Adjacent to
the chdR exporter gene homologue, we have identified
the chdA gene homologue, a putative tetR-like repressor
gene, analogously to the otc and ctc gene clusters (Fig.
1). Although chdA gene homologue is clearly a putative
tetR gene homologue (34), it shows little similarity to the
otc and ctc gene cluster counterparts otrR and ctcR, which
share 46 % identity and 57 % similarity (Fig. 3). Unex-
pectedly, the chdA gene shows the highest similarity to
the tetR gene homologues from Gram-negative bacteria
such as Klebsiella pneumoniae, Burkholderia spp. and E. coli
(38,39).
Inactivation of the otcG gene
Gene inactivation and overexpression was adopted
as the fastest way to examine a possible role of otcG
gene product in the regulation of OTC biosynthesis in S.
rimosus. As otcG is transcribed convergently with the
otrA ribosomal resistance gene, a simple and straight-
-forward single-cross over, suicide-disruption experi-
ment could be undertaken using a plasmid carrying a
truncated version of the otcG gene without influencing
the expression of the surrounding ORFs, particularly the
otrA gene (Fig. 1b). For this purpose, the truncated DNA
fragment of the otcG gene was inserted into the suicide
vector pIJ4026 (21).
The OTC-producing S. rimosus strains are well known
for their morphological instability (40). This instability is
promoted even further by gene manipulation, resulting
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Fig. 1. The clusters encoding tetracycline antibiotics: (a) chlortetracycline, (b) oxytetracycline and (c) chelocardin from S. aureofaciens,
S. rimosus and A. sulphurea, respectively. The magnified black arrows represent the putative regulatory genes ctc13, ctc11, and ctcR
from chlortetracycline gene cluster, their homologues otcG and otrR from oxytetracycline gene cluster, and chdA from chelocardin
gene cluster. The dashed (ctc14 and otrA) homologues at the left extremities of the clusters, and the dotted (ctc05, otrB and chdR)
homologues are the ribosomal and exporter resistance genes, respectively
in a great proportion of the colonies having a range of
morphological deformations, most often causing a sig-
nificant decrease of the OTC yield (29,30). Therefore,
only morphologically stable, well-sporulated colonies
were selected for further testing in order to reduce the
variability in OTC production caused by morphological
instability. Eighteen independent transformants carrying
the disrupted otcG gene were then tested in industrial
production medium, as described in Materials and Meth-
ods. The inactivation of the otcG gene did not abolish
the production of OTC. However, the production of
OTC in the wt:DotcG mutants was statistically signifi-
cantly reduced by more than 40 % in comparison with
the wt:pTS55 as demonstrated by the p-value of 0.0034
(Fig. 4). Inactivation of the otcG gene carried out under
the conditions applied during the experiments present-
ed in this work did not affect any of the morphological
characteristics of the 4018 strain.
Overexpression of the otcG gene
The entire otcG gene was amplified by PCR and
subcloned into the pTS55-based integrative vector (28)
to generate pTS55ermE-otcG. Expression of the otcG gene
was under the control of the ermE promoter (21), proven
to be functional in the S. rimosus 4018 strain. Forty-two
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Fig. 2. Alignment of the LuxR homologues from the Streptomyces rimosus, S. aureofaciens, and S. avermitilis strains. The Sigma-70 (re-
gion 4) domain involved in binding to the -35 promoter element via a helix-turn-helix motif is marked with *, the signal receiver do-
main is marked with –––, the TTA codon is highlighted in bold, the phosphorylation site is marked with , and the dimerization in-
terface is marked with +++
Fig. 3. Alignment of the TetR family of the regulators from the chelocardin (ChdA), chlortetracycline (CtcR) and oxytetracycline
(OtrR) gene clusters. Gray shadows indicate the conserved regions of the proteins
independent well-sporulated transformants from SM agar
medium were then tested for the production of OTC, as
described in the Materials and Methods. The introduc-
tion of a second copy of otcG, expressed under the con-
stitutive promoter ermE, did not yield any statistically
significant change in OTC production (p=0.1602) com-
pared to the S. rimosus 4018 strain containing pTS55
plasmid alone (Fig. 4).
Discussion
The aim of this work was to gain a fresh look into
the putative regulatory elements that may govern the
biosynthesis of OTC, through a comparative bioinforma-
tics study of the entire ctc, otc and chd gene clusters from
S. aureofaciens, S. rimosus and A. sulphurea, respectively.
The DNA sequence of part of the gene cluster encoding
OTC biosynthesis in S. rimosus ATCC10970 was recently
published by Zhang et al. (4), thus allowing us to com-
pare the entire gene clusters encoding CTC and OTC
biosynthesis. Importantly, gene clusters encoding OTC
and CTC biosynthesis were expressed heterologously in
S. lividans, confirming that all the necessary genes for
the biosynthesis of CTC and OTC were encoded by the
published DNA sequences (32,33).
Although the structures of the otc and ctc gene clus-
ters do differ significantly, the expected DNA homo-
logues with high identity/similarity can be identified in
both gene clusters (Figs. 1a and b). The annotation of
the otc gene clusters, which was carried out in both
strains of S. rimosus, the ATCC10970 and the M15883
strains, presumed that all the necessary genes encoding
OTC biosynthesis were flanked by the otrA (ribosomal)
resistance gene at one end, and the otrB (exporter) gene
on the other side of the gene cluster (2). However, led
by the annotation of the putative ORFs from the ctc
cluster, we have identified an additional ORF in the otc
gene cluster from a putative LAL (LuxR) family of trans-
criptional regulator, otcG (Fig. 1b), with a characteristic
nucleotide triphosphate (NTP) binding motif at the N-
-terminus and a helix-turn-helix (HTH) motif at its C-
-terminal side (Fig. 2). This gene lies within the EcoRI
fragment used by Binnie et al. (32) for the heterologous
production of OTC in S. lividans. Another objective of
this work was to determine whether the otcG gene prod-
uct is actually involved in OTC biosynthesis. To our
knowledge, the LAL (LuxR) family of regulatory pro-
teins has not been found previously in type II PKS gene
clusters. Little is understood of the overall role of these
proteins. Given the location of the otcG gene, flanking
externally the otrA gene (Fig. 1b), it was not unreason-
able to question whether this protein is actually in-
volved in the regulation of OTC biosynthesis. Simple
and straightforward gene disruption and overexpression
experiments were carried out to answer this question.
Inactivation of the otcG gene did not entirely abol-
ish, but instead significantly reduced OTC biosynthesis.
Overexpression of the otcG gene, through the ectopic ex-
pression of a second copy of the otcG gene did not influ-
ence the final OTC yield, thus demonstrating an only
'conditionally-positive' regulatory involvement of the
otcG gene product.
We have identified a rare TTA codon within the cod-
ing region of the otcG gene, which is characteristic of
many SARP genes (9). In the context of actinorhodin
biosynthesis, it has been demonstrated that the expres-
sion of an actII-ORF4 carrying a mutated TTA codon
leads to bldA-independent actinorhodin production (41).
However, the inactivation of the otcG gene did not lead
to any obvious morphological changes. Interestingly, the
ctc gene cluster counterpart of otcG, ctc13, does not con-
tain the rare leucine TTA codon, nor does the SARP
homologue from the ctc cluster contain the rare TTA
codon. The OTC biosynthesis in S. rimosus is not regu-
lated by the SARP family of regulatory elements located
in the otc gene cluster. A SARP family regulator is clear-
ly identified in the ctc gene cluster in S. aureofaciens. The
regulatory activity of the SARP-like regulatory protein
located outside the otc gene cluster, which positively
regulates OTC biosynthesis, is also a feasible option, as
demonstrated in S. coelicolor. It has been shown that the
actII-ORF4 gene product of the SARP family, which is
located in the actinorhodin gene cluster also influences
the expression of the spore pigment-encoding whiE lo-
cus and the gene clusters encoding the biosynthesis of
coelichenin and calcium-dependent (CDA) antibiotics,
and the genes governing the biosynthesis of undecylpro-
digiosin (9). McDowall et al. (15) predicted the existence
of a regulatory element involved in OTC biosynthesis,
when studying the phosphate-mediated control of OTC
production by S. rimosus. In this study they showed that
the transcription of the OTC biosynthetic genes otcC and
otcX is triggered by phosphate starvation, indicating
that the synthesis of OTC is controlled, at least in part,
at the level of transcription. Interestingly, promoters of
OTC biosynthesis overlap by tandem repeats, whose
spacing resembles that of the activation sites of the
OmpR family of transcriptional regulators (18). Based on
these findings, McDowall et al. (15) suggested that the
activator of the otc genes may be a member of the OmpR
family, most likely a member of the SARP group. How-
ever, no such type of regulatory element has been iden-
tified in the gene cluster encoding OTC biosynthesis (2).
On the other hand, the otcG gene product belongs to the
LAL (LuxR) family of transcriptional regulators, which
is classified as a member of the bigger group of the






























Fig. 4. Comparison of the oxytetracycline yields in Streptomyces
rimosus 4018 strains within a single fermentation run. The strain
with the truncated otcG gene (wt:DotcG; 9 independent trans-
formants) and the strain with the additional copy of the otcG
gene expressed under the ermE promoter (wt:pTS55ermE-otcG;
21 independent transformants) were compared to the S. rimosus
4018 with the pTS55 plasmid as a control
OmpR family of transcriptional regulators with a typical
conserved gene architecture consisting of a helix-turn-
-helix DNA binding motif, a signal receiver domain (Fig.
2). The otcG gene product may likely interfere with the
promoters of the genes involved in OTC biosynthesis, a
regulatory element which was predicted by McDowall et
al. (15). Interestingly, the putative phosphorylation site
in the ctc3 gene in S. aureofaciens seems to be mutated
from aspartic acid to glycine residue; thus, ctc13 might
even be inactive in the ctc gene cluster (Fig. 2).
Finally, no regulatory genes were identified in the
chelocardin gene cluster, with the exception of chdA
gene, a putative tetR gene homologues located beside
the chdR exporter gene homologue (Fig. 1c). It is reason-
able to believe that the chdR exporter gene is the only re-
sistance determinant present in the chd gene cluster. We
could not identify the otrA ribosomal resistance gene
homologue in the chd cluster. However, this is not sur-
prising, considering that the chelocardine does not target
the ribosome (42). However, it was very surprising that
the putative tetR homologue chdA shows very high simi-
larity to the tetR gene homologues present in the Gram-
-negative bacteria, considering that A. sulphurea taxo-
nomically belongs to the order of Actinomycetales, i.e. a
Gram-positive and the DNA GC-rich bacteria.
Conclusion
Regulatory elements from three gene clusters encod-
ing tetracycline biosynthesis have been compared. Sig-
nificant overall differences have been identified in the
regulatory elements that are likely governing the corre-
sponding biosynthetic pathways. When comparing the
tetR homologue (chdA) from the chelocardin-producing
strain A. sulphurea to the otc and ctc counterparts, unex-
pected evolutionary distance was identified. In this work,
a new regulatory element has been identified, not previ-
ously identified in the otc gene cluster, and clearly dem-
onstrated that the otcG gene, a member of the LAL
(LuxR) family of regulatory proteins, exerts a positive
role in the regulation of OTC biosynthesis. However, it
has only a 'conditionally positive' regulatory role, since
inactivation of the otcG gene does not completely abol-
ish OTC production. On the other hand, overexpression
of the otcG gene did not cause an increase of the OTC
yield, as it has often been demonstrated with, for exam-
ple, the SARP family of regulatory elements. Coupled
with the bioinformatics data and the work on phosphate
regulation carried out by McDowall et al. (15), it is pos-
sible to envisage a more complex, 'fine tuning' role of
the otcG gene product, which may likely be interfering
with the rather complex promoter regions of the genes
in the OTC gene cluster.
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